Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-05-21
DOI
10.1093/eurheartj/ehz387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
- (2018) Mika Hilvo et al. ATHEROSCLEROSIS
- Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER
- (2018) Marc S. Sabatine et al. CIRCULATION
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
- (2017) Daniel Lindholm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism
- (2017) Elena Ioana Braicu et al. Oncotarget
- Development and validation of a high-throughput LC–MS/MS assay for routine measurement of molecular ceramides
- (2016) Dimple Kauhanen et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 CohortHighlights
- (2016) Aki S. Havulinna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial InfarctionClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective
- (2016) Lotte Kaasenbrood et al. CIRCULATION
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
- (2016) Reijo Laaksonen et al. EUROPEAN HEART JOURNAL
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score
- (2013) Johannes A N Dorresteijn et al. HEART
- Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin andPCSK9Deficiency
- (2013) Kirill Tarasov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Omega-3 Fatty Acids and Cardiovascular Disease
- (2011) Dariush Mozaffarian et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Membrane lipids: where they are and how they behave
- (2008) Gerrit van Meer et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search